Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // September 17th, 2008 // 6:51 am
Another day, another bailout? That is not our focus here, of course, but watching Wall Street crumble can be distracting. Focusing on work, however, can be a good way to alleviate the pain and confusion. So, as always, we have rounded up a few items. Hope your day goes well…
Gilead Needs More Data For Cystic Fibrosis Drug (Reuters)
Glaxo Submits Restless Leg Drug For FDA Approval (AP)
Bayer Buys Germany’s Direvo For $299 Million (Bloomberg News)
Pfizer And Mannkind Strike Inhaled Insulin Deal (PharmaTimes)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Bayer, Cystic Fibrosis, Direvo, Exubera, Gilead Sciences, GlaxoSmithKline, Inhaled Insulin, MannKind, Pfizer, Restless Leg Syndrome